Galileo Research Facts No. 161: Can Galileo Therapy improve muscle function in Spinal Muscle Atrophy (SMA)?

Galileo Research Facts No. 161: Can Galileo Therapy improve muscle function in Spinal Muscle Atrophy (SMA)?

This study investigated the effects of Galileo Therapy in Spinal Muscle Atrophy (SMA, type II, III, IIIa, age 2-7) (Cologne Concept: 3×3 minutes, 10 session/week, 26 weeks). Galileo Therapy showed significant improvements in muscle function in Gross Motor Function Test (GMFM-66, +4%) and Hammersmith Functional Mobility Scale (HFMS, +9,5%). The following 6 months of standard therapy did not show further significant improvements…

Galileo Research Facts No. 157: Can Galileo Therapy improve muscle function and gait speed in children with Ataxia?

Galileo Research Facts No. 157: Can Galileo Therapy improve muscle function and gait speed in children with Ataxia?

This study shows the effect of Galileo Therapy (Cologne Concept: 3×3 minutes, 10 session/week, 26 weeks) in Ataxia patients (3-14 years, 2 groups: progressive and non-progressive). Both Galileo groups show significant improvements in GRMF66 (+7%), gait speed (+12%), 1MWT (+41%). In the following 6 months with standard therapy there was no additional relevant improvement in the parameters…

Galileo Research Facts No. 132: Can Galileo Therapy increase muscle power and decrease fall risk in Multiple Sclerosis (MS) patients?

Galileo Research Facts No. 132: Can Galileo Therapy increase muscle power and decrease fall risk in Multiple Sclerosis (MS) patients?

This pilot study reported the effects of Galileo Therapy on fall risk and muscle power in MS (multiple sclerosis) patients (20Hz, pos. 1.5, slightly flexed legs (20°), 5*1 min., 3/week, 8 weeks). Just 5 minutes Galileo Therapy 3 times per week showed decreased fall-risk and significantly improved balance (+12%), muscle function and muscle Power (+12%) as well as knee torque at flexor (+12) and extensor (15%)…